Literature DB >> 7959903

Differences in the expression of Ly-6C on neutrophils and monocytes following PI-PLC hydrolysis and cellular activation.

D B Jutila1, S Kurk, M A Jutila.   

Abstract

All leukocytes, except some subsets of lymphocytes, express Ly-6C. However, virtually all of the regulation studies of this antigen have been done on lymphocytes only. Recently we showed that monocytes and neutrophils express 10-100 times the level of Ly-6C expressed by lymphoid cells. We compared Ly-6C expression on neutrophils and monocytes following short-term cell activation induced by C5a or phorbol esters or treatment with phosphatidylinositol-specific phospholipase-C (PI-PLC). Activation of the neutrophil led to a rapid ( < 30 min) increase in surface expression of Ly-6C, but similar treatment had little effect on or slightly diminished the expression of the monocyte molecule. Prolonged treatment of the monocyte with IFN-gamma (24 h) led to increased Ly-6C expression. Low doses of TNF-alpha inhibited the up-regulation of Ly-6C induced by IFN-gamma. Similar to what has been described for the lymphocyte, the monocyte form of Ly-6C was hydrolyzed by PI-PLC treatment within 30 min. In contrast, the neutrophil molecule was unaffected by PI-PLC for up to 2 h. SDS-PAGE Western blot analysis demonstrated that the neutrophil and monocyte molecules were in the same molecular weight range (14-18 kDa Mr). Our results clearly show differences in the regulation of Ly-6C expression on monocytes versus neutrophils. Thus, it is likely that the potential function of Ly-6C will be unique for each cell.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959903     DOI: 10.1016/0165-2478(94)90056-6

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  8 in total

1.  Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants.

Authors:  Chiao-Wen Yang; Beverly S I Strong; Mark J Miller; Emil R Unanue
Journal:  J Immunol       Date:  2010-08-02       Impact factor: 5.422

Review 2.  Interleukin-8 and its receptor CXCR2 in atherosclerosis.

Authors:  W A Boisvert; L K Curtiss; R A Terkeltaub
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

3.  Estrogen modulates 7/4 antigen distribution within eccentrically contracted injured skeletal muscle.

Authors:  N D Fulkerson; J Nicholas; B St Pierre Schneider
Journal:  Biotech Histochem       Date:  2015-03-06       Impact factor: 1.718

4.  The myeloid 7/4-antigen defines recently generated inflammatory macrophages and is synonymous with Ly-6B.

Authors:  Marcela Rosas; Benjamin Thomas; Martin Stacey; Siamon Gordon; Philip R Taylor
Journal:  J Leukoc Biol       Date:  2010-04-16       Impact factor: 4.962

5.  Deletion of the NF-κB subunit p65/RelA in the hematopoietic compartment leads to defects in hematopoietic stem cell function.

Authors:  Sarah J Stein; Albert S Baldwin
Journal:  Blood       Date:  2013-05-13       Impact factor: 22.113

6.  Endometrial apoptosis and neutrophil infiltration during menstruation exhibits spatial and temporal dynamics that are recapitulated in a mouse model.

Authors:  Gregory M Armstrong; Jacqueline A Maybin; Alison A Murray; Moira Nicol; Catherine Walker; Philippa T K Saunders; Adriano G Rossi; Hilary O D Critchley
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

7.  A Novel CD48-Based Analysis of Sepsis-Induced Mouse Myeloid-Derived Suppressor Cell Compartments.

Authors:  Bei Jia; Chenchen Zhao; Guoli Li; Yaxian Kong; Yaluan Ma; Qiuping Wang; Beibei Wang; Hui Zeng
Journal:  Mediators Inflamm       Date:  2017-02-26       Impact factor: 4.711

8.  Ly6G deficiency alters the dynamics of neutrophil recruitment and pathogen capture during Leishmania major skin infection.

Authors:  Corinna L Kleinholz; Monika Riek-Burchardt; Elena A Seiß; Jonas Amore; Patricia Gintschel; Lars Philipsen; Philippe Bousso; Borna Relja; Burkhart Schraven; Juliane Handschuh; Juliane Mohr; Andreas J Müller
Journal:  Sci Rep       Date:  2021-07-23       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.